Answers are grounded in this paper and cite their sources.
A sensitive and specific radioimmunoassay for the insulin receptor has been developed employing receptor autoantibodies from the serum of a patient with insulin-resistant diabetes. The assay detects insulin binding sites at concentrations as low as 0.1 nanomolar; distinguishes between receptors originating from human placental membranes, human lymphoblastoid cells, and mouse liver membranes; and measures the receptor independently of its binding function. Down-regulation, or loss of binding after exposure to insulin, is associated with loss of immunoreactive receptor.
No takes yet. Share an insight, caveat, or question.
Harrison et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: